US5118673A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Uses of aloe products
Assignee: ALOE TECHNOLOGIES LLC
•
Filing: 1990-07-27
•
Granted: 1992-06-02
•
Expires: 2010-07-27
Abstract
Abstract Acemannan has been shown to be effective in treating a number of conditions where the principal mechanism of resolution or cure requires intervention by the patient's immune system. Acemannan has direct stimulatory effects on the immune system. Methods for treating cancer, viral diseases, respiratory and immune regulatory diseases, inflammations, infections and infestations by administering an acetylated mannan derivative, such as acemannan derived from aloe, are described. The method finds use in tissue cultures, animals and plants.
Inventors
- 👤 Robert H. Carpenter
- 👤 Harley R. McDaniel
- 👤 Bill H. McAnalley
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-31 23:23
CPC Classifications
C; C08; C08B; C08B37/00; C08B37/006; C08B37/0087; A; A61; A61K; A61K31/00; A61K31/70; A61K31/715; A61K31/736; A61K36/00; A61K36/18; A61K36/88; A61K36/886; C07; C07H; C07H15/00; C07H15/20; C07H15/24; C07H15/244; A61K39/00; A61K2039/555; A61K2039/55511; A61K2039/55583
Claims Analysis
Total Claims: 28
Claim 1
Independent Claim
34 words
A method for producing an antiviral effect in an animal infected with a virus, comprising: administering to said animal an amount of an acetylated mannan derivative sufficient to inhibit the replication of said virus.
Claim 2
Independent Claim
34 words
A method for producing an antiviral effect in an animal infected with a virus, comprising: administering to said animal an amount of an acetylated mannan derivative sufficient to inhibit the replication of said virus.
Claim 3
Dependent Claim
21 words
A method according to claim 1, wherein said animal comprises a human, a domesticated animal, a farm animal, or a bird.
Claim 4
Dependent Claim
17 words
A method according to claim 1, wherein said virus comprises a DNA virus or an RNA virus.
Claim 5
Dependent Claim
18 words
A method according to claim 1, wherein said virus comprises Iridoviridae, Poxviridae, Hepadnaviridae, Orthomyxoviridae, Paramyxoviridae, Rhabdoviridae, or Bunyaviridae.
Claim 6
Dependent Claim
16 words
A method according to claim 1, wherein said virus comprises Filoviridae, Nodaviridae, Togaviridae, Flaviviridae, or Arenaviridae.
Claim 7
Dependent Claim
13 words
A method according to claim 1, wherein said virus comprises Herpesviridae or Retroviridae.
Claim 8
Dependent Claim
13 words
A method according to claim 6 wherein said Retroviridae is an HIV virus.
Claim 9
Dependent Claim
13 words
A method according to claim 6 wherein said acetylated mannan derivative is acemannan.
Claim 10
Independent Claim
33 words
A method for producing an antiviral effect in an animal infected with a virus, comprising: administering to said animal an amount of an acetylated mannan derivative sufficient to enhance immuncompetency in said animal.
Claim 11
Independent Claim
33 words
A method for producing an antiviral effect in an animal infected with a virus, comprising: administering to said animal an amount of an acetylated mannan derivative sufficient to enhance immuncompetency in said animal.
Claim 12
Dependent Claim
21 words
A method according to claim 9, wherein said animal comprises a human, a domesticated animal, a farm animal, or a bird.
Claim 13
Dependent Claim
17 words
A method according to claim 9, wherein said virus comprises a DNA virus or an RNA virus.
Claim 14
Dependent Claim
18 words
A method according to claim 9, wherein said virus comprises Iridoviridae, Poxviridae, Hepadnaviridae, Orthomyxoviridae, Paramyxoviridae, Rhabdoviridae, or Bunyaviridae.
Claim 15
Dependent Claim
16 words
A method according to claim 9, wherein said virus comprises Filoviridae, Nodaviridae, Togaviridae, Flaviviridae, or Arenaviridae.
Claim 16
Dependent Claim
13 words
A method according to claim 9, wherein said virus comprises Herpesviridae or Retroviridae.
Claim 17
Dependent Claim
13 words
A method according to claim 14 wherein said Retroviridae is an HIV virus.
Claim 18
Dependent Claim
13 words
A method according to claim 9, wherein said acetylated mannan derivative is acemannan.
Claim 19
Independent Claim
33 words
A method for producing an antiviral effect in an animal infected with a virus, comprising: administering to said animal an amount of an acetylated mannan derivative sufficient to enhance antigenicity of said virus.
Claim 20
Independent Claim
33 words
A method for producing an antiviral effect in an animal infected with a virus, comprising: administering to said animal an amount of an acetylated mannan derivative sufficient to enhance antigenicity of said virus.
Claim 21
Dependent Claim
13 words
A method according to claim 17, wherein said acetylated mannan derivative is acemannan.
Claim 22
Independent Claim
36 words
A method for producing an antiviral effect in a tissue culture infected with a virus, comprising: administering to said tissue culture an amount of an acetylated mannan derivative sufficient to inhibit the replication of said virus.
Claim 23
Independent Claim
36 words
A method for producing an antiviral effect in a tissue culture infected with a virus, comprising: administering to said tissue culture an amount of an acetylated mannan derivative sufficient to inhibit the replication of said virus.
Claim 24
Dependent Claim
15 words
A method according to claim 19, wherein said tissue culture comprises an animal tissue culture.
Claim 25
Dependent Claim
13 words
A method according to claim 19, wherein said acetylated mannan derivative is acemannan.
Claim 26
Independent Claim
35 words
A method for producing an antiviral effect in an animal infected with a virus, comprising: administering to said animal an amount of an acetylated mannan derivative sufficient to alter glycosylation of glycoproteins of said virus.
Claim 27
Independent Claim
35 words
A method for producing an antiviral effect in an animal infected with a virus, comprising: administering to said animal an amount of an acetylated mannan derivative sufficient to alter glycosylation of glycoproteins of said virus.
Claim 28
Dependent Claim
13 words
A method according to claim 22, wherein said acetylated mannan derivative is acemannan.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-06-02 | 1995-12-02 | 1996-06-02 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-06-02 | 1999-12-02 | 2000-06-02 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-06-02 | 2003-12-02 | 2004-06-02 | $7700.00 | Window Closed / Lapsed |